Biomarkers for kidney involvement in pediatric lupus

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Lupus nephritis (LN), the renal involvement in systemic lupus erythematosus, is currently diagnosed by histopathology obtained by percutaneous renal biopsy and is associated with increased morbidity and mortality in both adults and children. LN is more prevalent and severe in children, requiring aggressive and prolonged immunosuppression. The consequences of the diagnosis and its treatment have devastating long-term effects on the growth, well-being and quality of life of affected children. The paucity of reliable clinical indicators of the presence and severity of renal involvement have contributed to a halt in the reduction of progression to end-stage renal disease in recent years. Here, we discuss the recent development of biomarkers in the management of LN and their role as therapeutic targets.

Original languageEnglish (US)
Pages (from-to)529-543
Number of pages15
JournalBiomarkers in Medicine
Volume9
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Lupus Nephritis
Pediatrics
Biopsy
Biomarkers
Kidney
Systemic Lupus Erythematosus
Immunosuppression
Chronic Kidney Failure
Quality of Life
Morbidity
Mortality
Therapeutics
Growth

Keywords

  • children
  • lupus nephritis
  • noninvasive biomarkers
  • pathogenesis
  • TWEAK

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Drug Discovery

Cite this

Biomarkers for kidney involvement in pediatric lupus. / Goilav, Beatrice; Putterman, Chaim; Rubinstein, Tamar.

In: Biomarkers in Medicine, Vol. 9, No. 6, 01.06.2015, p. 529-543.

Research output: Contribution to journalArticle

@article{9420f23571f14e52aaaf57d443a67505,
title = "Biomarkers for kidney involvement in pediatric lupus",
abstract = "Lupus nephritis (LN), the renal involvement in systemic lupus erythematosus, is currently diagnosed by histopathology obtained by percutaneous renal biopsy and is associated with increased morbidity and mortality in both adults and children. LN is more prevalent and severe in children, requiring aggressive and prolonged immunosuppression. The consequences of the diagnosis and its treatment have devastating long-term effects on the growth, well-being and quality of life of affected children. The paucity of reliable clinical indicators of the presence and severity of renal involvement have contributed to a halt in the reduction of progression to end-stage renal disease in recent years. Here, we discuss the recent development of biomarkers in the management of LN and their role as therapeutic targets.",
keywords = "children, lupus nephritis, noninvasive biomarkers, pathogenesis, TWEAK",
author = "Beatrice Goilav and Chaim Putterman and Tamar Rubinstein",
year = "2015",
month = "6",
day = "1",
doi = "10.2217/bmm.15.25",
language = "English (US)",
volume = "9",
pages = "529--543",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Biomarkers for kidney involvement in pediatric lupus

AU - Goilav, Beatrice

AU - Putterman, Chaim

AU - Rubinstein, Tamar

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Lupus nephritis (LN), the renal involvement in systemic lupus erythematosus, is currently diagnosed by histopathology obtained by percutaneous renal biopsy and is associated with increased morbidity and mortality in both adults and children. LN is more prevalent and severe in children, requiring aggressive and prolonged immunosuppression. The consequences of the diagnosis and its treatment have devastating long-term effects on the growth, well-being and quality of life of affected children. The paucity of reliable clinical indicators of the presence and severity of renal involvement have contributed to a halt in the reduction of progression to end-stage renal disease in recent years. Here, we discuss the recent development of biomarkers in the management of LN and their role as therapeutic targets.

AB - Lupus nephritis (LN), the renal involvement in systemic lupus erythematosus, is currently diagnosed by histopathology obtained by percutaneous renal biopsy and is associated with increased morbidity and mortality in both adults and children. LN is more prevalent and severe in children, requiring aggressive and prolonged immunosuppression. The consequences of the diagnosis and its treatment have devastating long-term effects on the growth, well-being and quality of life of affected children. The paucity of reliable clinical indicators of the presence and severity of renal involvement have contributed to a halt in the reduction of progression to end-stage renal disease in recent years. Here, we discuss the recent development of biomarkers in the management of LN and their role as therapeutic targets.

KW - children

KW - lupus nephritis

KW - noninvasive biomarkers

KW - pathogenesis

KW - TWEAK

UR - http://www.scopus.com/inward/record.url?scp=84931472739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931472739&partnerID=8YFLogxK

U2 - 10.2217/bmm.15.25

DO - 10.2217/bmm.15.25

M3 - Article

C2 - 26079958

AN - SCOPUS:84931472739

VL - 9

SP - 529

EP - 543

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 6

ER -